David Sinclair

592 total citations
15 papers, 459 citations indexed

About

David Sinclair is a scholar working on Cellular and Molecular Neuroscience, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, David Sinclair has authored 15 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Pathology and Forensic Medicine and 4 papers in Epidemiology. Recurrent topics in David Sinclair's work include Neurotransmitter Receptor Influence on Behavior (4 papers), Substance Abuse Treatment and Outcomes (4 papers) and Alcohol Consumption and Health Effects (4 papers). David Sinclair is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (4 papers), Substance Abuse Treatment and Outcomes (4 papers) and Alcohol Consumption and Health Effects (4 papers). David Sinclair collaborates with scholars based in Finland, United States and United Kingdom. David Sinclair's co-authors include Hannu Alho, Antti Holopainen, Erkki Vuori, Jimee Hwang, Eugenie Poirot, Jacek Skarbinski, S. Patrick Kachur, Laurence Slutsker, Jari Lahti and Jochen Wolffgramm and has published in prestigious journals such as Cochrane Database of Systematic Reviews, The British Journal of Psychiatry and Drug and Alcohol Dependence.

In The Last Decade

David Sinclair

14 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Sinclair Finland	11	261	128	86	81	55	15	459
Lisa McCall United States	8	167 0.6×	152 1.2×	132 1.5×	37 0.5×	57 1.0×	10	576
Y. Riemer Austria	10	197 0.8×	199 1.6×	88 1.0×	72 0.9×	56 1.0×	20	418
Jean Falcioni United States	7	237 0.9×	172 1.3×	66 0.8×	83 1.0×	58 1.1×	8	336
Jessica N. Jenkins United States	16	353 1.4×	162 1.3×	42 0.5×	85 1.0×	49 0.9×	28	765
Manzumeh Shamsi Meymandi Iran	17	79 0.3×	57 0.4×	84 1.0×	48 0.6×	48 0.9×	53	562
Vanessa Bloch France	16	100 0.4×	122 1.0×	173 2.0×	123 1.5×	58 1.1×	72	841
T. Y. Slavina Russia	8	127 0.5×	149 1.2×	211 2.5×	147 1.8×	40 0.7×	9	519
Thilo Beck Switzerland	10	190 0.7×	178 1.4×	38 0.4×	89 1.1×	37 0.7×	12	360
Susette Welm United States	6	248 1.0×	95 0.7×	120 1.4×	119 1.5×	33 0.6×	7	426
Shirley Linzy Israel	8	115 0.4×	98 0.8×	171 2.0×	78 1.0×	45 0.8×	10	412

Countries citing papers authored by David Sinclair

Since Specialization

Citations

This map shows the geographic impact of David Sinclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sinclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sinclair more than expected).

Fields of papers citing papers by David Sinclair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sinclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sinclair. The network helps show where David Sinclair may publish in the future.

Co-authorship network of co-authors of David Sinclair

This figure shows the co-authorship network connecting the top 25 collaborators of David Sinclair. A scholar is included among the top collaborators of David Sinclair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sinclair. David Sinclair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Lahti, Tuuli, Jukka Halme, Maiju Pankakoski, David Sinclair, & Hannu Alho. (2025). Treatment of Pathological Gambling with Naltrexone Pharmacotherapy and Brief Intervention: A Pilot Study. Psychopharmacology Bulletin. 43(3). 35–44.

2.

Lahti, Jari, Hannu Alho, Leena Kovanen, et al.. (2013). mu-Opioid Receptor Gene (OPRM1) Polymorphism A118G: Lack of Association in Finnish Populations with Alcohol Dependence or Alcohol Consumption. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations

3.

Lahti, Jari, Hannu Alho, Leena Kovanen, et al.. (2013). µ-Opioid Receptor Gene (OPRM1) Polymorphism A118G: Lack of Association in Finnish Populations with Alcohol Dependence or Alcohol Consumption. Alcohol and Alcoholism. 48(5). 519–525. 27 indexed citations

4.

Poirot, Eugenie, Jacek Skarbinski, David Sinclair, et al.. (2013). Mass drug administration for malaria. Cochrane Database of Systematic Reviews. 9(12). CD008846–CD008846. 122 indexed citations

5.

Lahti, Tuuli, Jukka Halme, Maiju Pankakoski, David Sinclair, & Hannu Alho. (2012). Characteristics of Treatment Seeking Finnish Pathological Gamblers: Baseline Data from a Treatment Study. International Journal of Mental Health and Addiction. 11(3). 307–314. 11 indexed citations

6.

Heinälä, Pekka, Tuuli Lahti, David Sinclair, et al.. (2012). Analysis of naltrexone and its metabolite 6-beta-naltrexol in serum with high-performance liquid chromatography. BMC Research Notes. 5(1). 439–439. 3 indexed citations

7.

Sinclair, David, et al.. (2012). Effect of opioid antagonists on sex hormone secretion.. PubMed. 35(2). 227–30. 11 indexed citations

8.

Lahti, Tuuli, et al.. (2011). The impacts of nitrous oxide gas on sleep quality during alcohol withdrawal. BMC Research Notes. 4(1). 108–108. 7 indexed citations

9.

Lahti, Jari, et al.. (2008). Treatment of alcohol dependence in patients with co-morbid major depressive disorder – predictors for the outcomes with memantine and escitalopram medication. Substance Abuse Treatment Prevention and Policy. 3(1). 20–20. 35 indexed citations

10.

Alho, Hannu, David Sinclair, Erkki Vuori, & Antti Holopainen. (2006). Abuse liability of buprenorphine–naloxone tablets in untreated IV drug users. Drug and Alcohol Dependence. 88(1). 75–78. 154 indexed citations

11.

Sarviharju, Maija, Jarno Riikonen, Pia Jaatinen, et al.. (2004). Survival of AA and ANA Rats During Lifelong Ethanol Exposure. Alcoholism Clinical and Experimental Research. 28(1). 93–97. 11 indexed citations

12.

Boening, Jobst, Rainer Spanagel, Jochen Wolffgramm, et al.. (2001). Pharmacological Relapse Prevention in Alcohol Dependence: From Animal Models to Clinical Trials. Alcoholism Clinical and Experimental Research. 25(Supplement). 127S–131S. 27 indexed citations

13.

Boening, Jobst, Rainer Spanagel, Jochen Wolffgramm, et al.. (2001). Pharmacological Relapse Prevention in Alcohol Dependence: From Animal Models to Clinical Trials. Alcoholism Clinical and Experimental Research. 25(s1). 25 indexed citations

14.

Fleming, Colin, et al.. (1998). A fucosidosis patient with relative longevity and a missense mutation in exon 7 of the α‐fucosidase gene. Journal of Inherited Metabolic Disease. 21(6). 688–689. 10 indexed citations

15.

Seppä, Kaija, et al.. (1994). Hidden Alcohol Abuse Among Women. The British Journal of Psychiatry. 164(4). 544–546. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact